Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f7b84b3b86b864ab5efe079cde1d354 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dfa8370e4faf75463c509a4686143a1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 |
filingDate |
2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faa370d7def02edfa056fea0f8921ff1 |
publicationDate |
2009-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009121496-A2 |
titleOfInvention |
Use of a biologically active blood serum for the treatment of a disorder charcterized in a reduced function of a gaba receptor |
abstract |
The present invention relates to the use of a pharmacologically active blood serum product producible by a method comprising electrostimulation of a non-human animal, withdrawal of blood from said animal, isolation of serum from said blood, and gamma irradiation of said serum for the prevention or treatment of a disorder characterized in a reduced GABA receptor function. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639281-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959958-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195153-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492444-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172797-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792254-B2 |
priorityDate |
2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |